Skip to content
Monday, November 16, 2026
Core Slot Daily

Users Coming Off Anti-Obesity Medications Gain Back Pounds Four Times Faster Than People Using Diet and Exercise

Image of medical syringe and scale
Weight management involves ongoing approaches.

New research reveals that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds far faster than those who stop conventional lifestyle regimens.

Research printed in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Users buying these treatments must be informed of the danger of quick rebound weight gain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to starting mass in about a year and a half.

Weighing Approaches

The analysis, which looked at dozens of trials involving over 9,000 of patients, compared the results of these new drugs with conventional dieting.

The team point out that individuals who lose weight through diet and exercise generally have a more gradual creep back—perhaps 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Nutrition scientists believe the mode of action of the jabs accounts for the accelerated regain.

The injections imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Long-term administration of the hormone levels several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement means appetite is no longer kept in check, making overeating much more probable."

An Ongoing Disease?

Medical guidelines advise the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.

Many experts argue that, given the likelihood of relapse, the treatment might need to be life-long.

This perspective is echoed by drug manufacturers, who say that the findings "underscore the chronic nature of excess weight," akin to managing diseases like diabetes.

Patient Testimonies

Users who have discontinued the jabs explain a sudden return of appetite.

"It was like a trigger flipping and you're instantly starving," described a patient.

The struggle is compounded if users have not developed permanent dietary or behavioural changes during therapy.

Widespread Adoption

Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with demand remaining high.

  • Use is higher among women than males.
  • The middle-aged age group shows the greatest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than public health services.

In conclusion, experts emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent cure and long-term success hinges on ongoing behavioural changes.

About the author

Barry Forbes

Marcus Vance is a gaming journalist with over a decade of experience covering slot machines and casino trends worldwide.

Core Slot Daily

Type to search articles.